CENPF与PLA2G4A的相互作用通过调节mTORC1和NF-κB通路来促进质瘤的生长
Junhong Li1, Moxuan Zhang2, Qiang Sun3
1Linyi People's Hospital, Shandong Second Medical University, Linyi, Shandong Province, 276000, China.
Cancer cell international
|March 2, 2025
概括
中心蛋白蛋白F (CENPF) 通过与PLA2G4A相互作用来促进质瘤的发展. 抑制这种相互作用为质瘤治疗和耐药性提供了一个新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 质瘤是一种常见的中枢神经系统恶性瘤,治疗选择有限.
- 中心蛋白蛋白F (CENPF) 涉及瘤发生,但其在质瘤中的作用尚未得到研究.
研究的目的:
- 研究CENPF在质瘤中的作用.
- 确定CENPF作为质瘤的潜在治疗点.
主要方法:
- 分析了TCGA,CGGA和GEO数据库的CENPF表达和临床数据.
- 进行了免疫组织化学,西部斑,GSEA,分子对接和Co-IP.
- 在CENPF沉默后利用了细胞增殖,入侵,细胞循环和细胞亡测试.
主要成果:
- 在质瘤中,CENPF的表达很高,与预后不佳相关.
- CENPF沉默会诱导G2/M阶段停止和亡,通过mTORC1.1.影响EMT.
- CENPF与PLA2G4A相互作用,促进下游信号和瘤进展.
结论:
- 通过与PLA2G4A.的相互作用,CENPF促进了质瘤瘤的发生.
- 针对CENPF-PLA2G4A相互作用,为质瘤提供了一个新的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K


